First‐in‐human High‐cumulative‐dose Stem Cell Therapy in Idiopathic Pulmonary Fibrosis With Rapid Lung Function Decline

Stem cells translational medicine - United States
doi 10.1002/sctm.19-0037
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment

Respiratory Medicine
PulmonaryRespiratory Medicine
2019English

Prognosis of Non-Small-Cell Lung Cancer in Patients With Idiopathic Pulmonary Fibrosis

Scientific Reports
Multidisciplinary
2019English

Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis

Cell Transplantation
TransplantationBiomedical EngineeringCell Biology
2018English

Triple Therapy for Idiopathic Pulmonary Fibrosis

Thorax
PulmonaryRespiratory Medicine
2012English

Characterization of Cell Proliferation in Idiopathic Pulmonary Fibrosis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Allogenic Stem Cell Therapy Improves Right Ventricular Function by Improving Lung Pathology in Rats With Pulmonary Hypertension

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2009English

Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Recombinant Human Pentraxin-2 Therapy in Patients With Idiopathic Pulmonary Fibrosis: Safety, Pharmacokinetics and Exploratory Efficacy

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy